You are here: Home » News-IANS » Science-Tech
Business Standard

Scientists solve blood clot deaths in cancer patients

IANS  |  Wellington 

scientists have unlocked the mystery of why so many patients die of blood clots while undergoing chemotherapy in a study.

Chemotherapy stimulates release of tiny bubbles from the surface of cells, causing the potentially fatal clots, said the study by University of Otago researchers that came out on Wednesday, Xinhua news reported.

Most deaths from were caused by uncontrolled growth of tumour in vital organs, but the second most common way that kills is by triggering blood clotting resulting in thrombosis.

The clots cause blockage of major blood vessels, preventing oxygen and nutrients to vital organs.

Despite being life-prolonging, chemotherapy is thus associated with a six-to-seven fold increase in the risk of thrombosis in patients.

The link between and thrombosis was noted over 100 years ago, but the reasons for the association had been elusive, Associate Professor Alex McLellan said in a statement.

McLellan's team discovered cells treated with chemotherapy releasing lipid-rich bubbles from their membranes that activated coagulation (clotting) processes.

"We now have insight into how these bubbles from dying cells may cause thrombosis during chemotherapy," McLellan said.

The research had showed that certain solid cancers were more active in promoting blood coagulation, as compared to lymphomas.

"A general pattern is that cancers such as pancreatic, lung and brain cancers carry the largest risk of thrombotic events," he said.

The study opened the possibility of developing inhibitors to the major coagulation pathway identified in cells.--IANS

in/

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Scientists solve blood clot deaths in cancer patients

New Zealand scientists have unlocked the mystery of why so many cancer patients die of blood clots while undergoing chemotherapy in a study.

scientists have unlocked the mystery of why so many patients die of blood clots while undergoing chemotherapy in a study.

Chemotherapy stimulates release of tiny bubbles from the surface of cells, causing the potentially fatal clots, said the study by University of Otago researchers that came out on Wednesday, Xinhua news reported.

Most deaths from were caused by uncontrolled growth of tumour in vital organs, but the second most common way that kills is by triggering blood clotting resulting in thrombosis.

The clots cause blockage of major blood vessels, preventing oxygen and nutrients to vital organs.

Despite being life-prolonging, chemotherapy is thus associated with a six-to-seven fold increase in the risk of thrombosis in patients.

The link between and thrombosis was noted over 100 years ago, but the reasons for the association had been elusive, Associate Professor Alex McLellan said in a statement.

McLellan's team discovered cells treated with chemotherapy releasing lipid-rich bubbles from their membranes that activated coagulation (clotting) processes.

"We now have insight into how these bubbles from dying cells may cause thrombosis during chemotherapy," McLellan said.

The research had showed that certain solid cancers were more active in promoting blood coagulation, as compared to lymphomas.

"A general pattern is that cancers such as pancreatic, lung and brain cancers carry the largest risk of thrombotic events," he said.

The study opened the possibility of developing inhibitors to the major coagulation pathway identified in cells.--IANS

in/

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Scientists solve blood clot deaths in cancer patients

scientists have unlocked the mystery of why so many patients die of blood clots while undergoing chemotherapy in a study.

Chemotherapy stimulates release of tiny bubbles from the surface of cells, causing the potentially fatal clots, said the study by University of Otago researchers that came out on Wednesday, Xinhua news reported.

Most deaths from were caused by uncontrolled growth of tumour in vital organs, but the second most common way that kills is by triggering blood clotting resulting in thrombosis.

The clots cause blockage of major blood vessels, preventing oxygen and nutrients to vital organs.

Despite being life-prolonging, chemotherapy is thus associated with a six-to-seven fold increase in the risk of thrombosis in patients.

The link between and thrombosis was noted over 100 years ago, but the reasons for the association had been elusive, Associate Professor Alex McLellan said in a statement.

McLellan's team discovered cells treated with chemotherapy releasing lipid-rich bubbles from their membranes that activated coagulation (clotting) processes.

"We now have insight into how these bubbles from dying cells may cause thrombosis during chemotherapy," McLellan said.

The research had showed that certain solid cancers were more active in promoting blood coagulation, as compared to lymphomas.

"A general pattern is that cancers such as pancreatic, lung and brain cancers carry the largest risk of thrombotic events," he said.

The study opened the possibility of developing inhibitors to the major coagulation pathway identified in cells.--IANS

in/

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard